BioMas
Developer of innovative pharmaceuticals, has found an integrin-inhibitory activity of novel small tellurium molecules, based on their interaction with thiols. Integrins are emerging therapeutic targets in many human pathologies. The ability to efficiently control their activation/deactivation has become a central focus of therapy.